Emerging Clinical Approaches to the Effective Management of Diabetes and Risks

Please use as an example only Emerging Clinical Approaches to the Effective Management of Diabetes and Risks According to the American Diabetes Association (ADA) (2019), treatment for diabetes mellitus (DM) should be proactive instead of reactive. The ADA (2019), recommended testing adults that are overweight/obese (BMI ≥25 kg/m2) with one/more risk factors for prediabetes and type II DM. According to the ADA (2019), children/adolescents that are overweight (BMI ≥85th percentile), obese (BMI ≥95th percentile), and have other risks for DM should be screened for prediabetes/type II DM after the onset of puberty or at 10 years of age. If the results are within normal limits repeat the test within a minimum of a three-year interval (American diabetes association, 2019). If the results are abnormal, health care providers must implement treatment plans promptly, utilize evidence-based guidelines, and collaborate with patients based on their preferences, prognoses, and comorbidities (American diabetes association, 2019). In doing so, improves the quality of care provided and the health of the patients (American diabetes association, 2019). To prevent or delay the onset of type II DM, health care providers should monitor for the development of type II DM in patients with prediabetes annually (American diabetes association, 2019). The ADA (2019), recommended referring prediabetic patients to an intensive behavioral lifestyle intervention program, that would help them achieve/maintain a 7% loss of body weight and increase their physical activity to moderate intensity. According to the ADA (2019), several studies showed that intensive lifestyle modifications reduced the incidence of type II DM. The ADA (2019), stated that the incidence of DM was reduced by 58% over three years in the Diabetes Prevention Program (DPP). The A1c test is primarily used to assess glycemic control. According to the ADA (2019), health care providers should obtain the A1c level test at least two times a year in patients with stable glycemic control and quarterly in patients who are not meeting their glycemic goals. The ADA (2019), stated that a glycemic level of less than 7% is a reasonable level for adults. The most common drug prescribed for type II DM is Metformin (American diabetes association, 2019). Cardiovascular diseases such as heart failure, coronary heart disease, cerebrovascular disease, and peripheral arterial disease are the most common cause of morbidity/mortality of patients with diabetes. To prevent and manage cardiovascular risks among diabetics, risk factors such as hypertension, dyslipidemia, obesity, a family history of coronary disease, smoking, chronic kidney disease, and albuminuria should be assessed yearly (American diabetes association, 2019).

References

American diabetes association. (2019). Standards of medical care in diabetes—2019 abridged for primary care providers. American Diabetes Association, 37(1), 11-34. doi:10.2337/cd18-0105

ANSWER. PAPER DETAILS
Academic Level	Masters
Subject Area	Nursing
Paper Type	Coursework
Number of Pages	2 Page(s)/550 words
Sources	2
Format	APA 6
Spacing	Double Spacing

---

Reload

If this is not the paper you were searching for, you can order your 100% plagiarism free, custom written paper now!